- Home
- SHIP vs ZURA Comparison
SHIP vs ZURA Comparison
Compare SHIP & ZURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SHIP
- ZURA
- Stock Information
- Founded
- SHIP 2008
- ZURA 2022
- Country
- SHIP Greece
- ZURA United States
- Employees
- SHIP N/A
- ZURA N/A
- Industry
- SHIP Marine Transportation
- ZURA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SHIP Consumer Discretionary
- ZURA Health Care
- Exchange
- SHIP Nasdaq
- ZURA Nasdaq
- Market Cap
- SHIP 170.0M
- ZURA 137.2M
- IPO Year
- SHIP 2007
- ZURA N/A
- Fundamental
- Price
- SHIP $8.31
- ZURA $3.97
- Analyst Decision
- SHIP Strong Buy
- ZURA Buy
- Analyst Count
- SHIP 1
- ZURA 9
- Target Price
- SHIP $11.00
- ZURA $11.00
- AVG Volume (30 Days)
- SHIP 141.4K
- ZURA 4.3M
- Earning Date
- SHIP 11-07-2025
- ZURA 11-07-2025
- Dividend Yield
- SHIP 9.23%
- ZURA N/A
- EPS Growth
- SHIP N/A
- ZURA N/A
- EPS
- SHIP 0.73
- ZURA N/A
- Revenue
- SHIP $147,718,000.00
- ZURA N/A
- Revenue This Year
- SHIP N/A
- ZURA N/A
- Revenue Next Year
- SHIP $11.82
- ZURA N/A
- P/E Ratio
- SHIP $11.30
- ZURA N/A
- Revenue Growth
- SHIP 1.66
- ZURA N/A
- 52 Week Low
- SHIP $4.78
- ZURA $0.97
- 52 Week High
- SHIP $10.16
- ZURA $4.91
- Technical
- Relative Strength Index (RSI)
- SHIP 49.34
- ZURA 65.11
- Support Level
- SHIP $8.14
- ZURA $3.15
- Resistance Level
- SHIP $8.50
- ZURA $3.51
- Average True Range (ATR)
- SHIP 0.23
- ZURA 0.32
- MACD
- SHIP 0.01
- ZURA -0.04
- Stochastic Oscillator
- SHIP 61.90
- ZURA 55.94
About SHIP Seanergy Maritime Holdings Corp.
Seanergy Maritime Holdings Corp is an international shipping company that provides marine dry bulk transportation services through the ownership and operation of dry bulk vessels. It generates a majority of its revenue from the vessels. The company's fleet of vessels includes Blueship, Meiship, Kaizenship, Iconship, Titanship, Flagship, Paroship, Worldship, Hellasship, Partnership, Championship, Patriotship, Dukeship, Honorship, Fellowship, Knightship, Lordship, Premiership, Squireship, and Friendship.
About ZURA Zura Bio Limited
Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.